apomorphine HCl injection

DRUG4 trials

Sponsors

Mylan Bertek Pharmaceuticals

Conditions

Parkinson Disease

Phase 2

Continued Efficacy of Apomorphine After Previous Exposure of at Least Three Months

CompletedNCT00200512

Mylan Bertek PharmaceuticalsParkinson Disease

Start: 1999-09-30End: 1999-11-30Target: 16Updated: 2005-12-16

Phase 3

Long Term Safety and Efficacy of SC Apomorphine in Treatment of Off Episodes in Late-Stage Parkinson's Disease

CompletedNCT00142545

Mylan Bertek PharmaceuticalsParkinson Disease

Start: 1999-07-31End: 2005-07-31Target: 800Updated: 2005-09-02

A Sub-Study With Patients in APO401 to Evaluate Adverse Events During Dose Introduction in Apomorphine-naïve Patients.

CompletedNCT00145171

Mylan Bertek PharmaceuticalsParkinson Disease

Start: 2001-02-28End: 2002-08-31Target: 56Updated: 2005-09-05

Continued Efficacy and Safety of Apomorphine in Patients With Late-Stage Parkinsons Disease

CompletedNCT00200525

Mylan Bertek PharmaceuticalsParkinson Disease

Start: 2001-07-31End: 2002-06-30Target: 60Updated: 2005-12-16